Urovant Sciences Ltd (UROV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | UROV | RGNX | PHVS | ||
Company | Urovant Sciences Ltd | Regenxbio Inc | Pharvaris N.V. | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 16.23 | 11.05 | 16.72 | ||
High | 16.24 | 11.28 | 17.50 | ||
Low | 16.21 | 10.49 | 16.53 | ||
Last | 16.24 | 10.63 | 17.43 | ||
Change | +0.01 | -0.27 | +0.78 | ||
% Change | +0.06% | -2.48% | +4.68% | ||
Volume | 1,739,000 | 538,500 | 152,800 | ||
20-Day Average Volume | 143,510 | 768,510 | 86,295 | ||
Previous Close | 16.23 | 10.90 | 16.65 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | No | ||
Technicals | |||||
20-Day Moving Average | 16.21 | 12.09 | 17.85 | ||
20-Day Raw Stochastic | 87.10% | 3.70% | 37.39% | ||
20-Day Relative Strength | 65.56% | 30.21% | 44.83% | ||
Weighted Alpha | +6.45 | -56.28 | -20.06 | ||
Today's Opinion | 100% Buy | 88% Sell | 100% Sell | ||
Previous Opinion | 100% Buy | 88% Sell | 100% Sell | ||
Last Month's Opinion | 96% Buy | 100% Sell | 88% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | unch since 03/19/21 | -9.15% since 06/28/24 | -7.29% since 06/28/24 | ||
Low | 16.20 on 03/24/21 | 10.49 on 07/08/24 | 16.05 on 07/05/24 | ||
High | 16.25 on 03/25/21 | 11.83 on 07/01/24 | 20.51 on 07/01/24 | ||
1-Month | |||||
%Chg | +0.43% since 02/26/21 | -24.50% since 06/07/24 | +11.23% since 06/07/24 | ||
Low | 16.10 on 03/02/21 | 10.49 on 07/08/24 | 15.52 on 06/10/24 | ||
High | 16.26 on 03/19/21 | 14.01 on 06/11/24 | 20.88 on 06/18/24 | ||
3-Month | |||||
%Chg | +1.25% since 12/24/20 | -44.61% since 04/08/24 | -23.35% since 04/08/24 | ||
Low | 16.03 on 12/30/20 | 10.49 on 07/08/24 | 15.37 on 06/07/24 | ||
High | 16.26 on 03/19/21 | 19.77 on 04/09/24 | 25.50 on 05/02/24 | ||
6-Month | |||||
%Chg | +76.14% since 09/25/20 | -26.39% since 01/08/24 | -32.99% since 01/08/24 | ||
Low | 7.15 on 11/02/20 | 10.49 on 07/08/24 | 15.37 on 06/07/24 | ||
High | 16.26 on 03/19/21 | 28.80 on 03/05/24 | 33.00 on 02/06/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 531,746 | 536,890 | 530,136 | ||
Shares Outstanding, K | 32,743 | 49,256 | 31,840 | ||
Annual Sales | 0 | 90,240,000 | 0 | ||
Annual Net Income | -146,750,000 | -263,490,000 | -109,180,000 | ||
Last Quarter Sales | 0 | 15,620,000 | 0 | ||
Last Quarter Net Income | -46,800,000 | -63,330,000 | -30,420,000 | ||
60-Month Beta | 2.35 | 1.26 | -3.10 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | -1.38 on 05/08/24 | -0.56 on 05/08/24 | ||
Latest Earnings Date | 02/11/21 | 08/07/24 | 08/05/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |